Julia Guez-Haddad
Overview
Explore the profile of Julia Guez-Haddad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nachum-Raines S, Gamliel N, Wasserman D, Qassem N, Sher I, Guez-Haddad J, et al.
bioRxiv
. 2025 Mar;
PMID: 40027684
Dynamic oscillations in the phosphorylation and ubiquitination of key proliferative regulators are defining features of the eukaryotic cell cycle. Resetting the cell cycle at the mitosis-to-G1 transition requires activation of...
2.
Khazma T, Grossman A, Guez-Haddad J, Feng C, Dabas H, Sain R, et al.
Cell Rep
. 2023 Aug;
42(9):113026.
PMID: 37635352
Wallerian axonal degeneration (WD) does not occur in the nematode C. elegans, in contrast to other model animals. However, WD depends on the NADase activity of SARM1, a protein that...
3.
Makaros Y, Raiff A, Timms R, Wagh A, Gueta M, Bekturova A, et al.
Mol Cell
. 2023 May;
83(11):1921-1935.e7.
PMID: 37201526
Although most eukaryotic proteins are targeted for proteasomal degradation by ubiquitination, a subset have been demonstrated to undergo ubiquitin-independent proteasomal degradation (UbInPD). However, little is known about the molecular mechanisms...
4.
Khazma T, Golan-Vaishenker Y, Guez-Haddad J, Grossman A, Sain R, Weitman M, et al.
Cell Mol Life Sci
. 2023 Feb;
80(3):68.
PMID: 36814037
No abstract available.
5.
Khazma T, Golan-Vaishenker Y, Guez-Haddad J, Grossman A, Sain R, Weitman M, et al.
Cell Mol Life Sci
. 2022 Dec;
80(1):16.
PMID: 36564647
In recent years, there has been growing interest in SARM1 as a potential breakthrough drug target for treating various pathologies of axon degeneration. SARM1-mediated axon degeneration relies on its TIR...
6.
Sporny M, Guez-Haddad J, Khazma T, Yaron A, Dessau M, Shkolnisky Y, et al.
Elife
. 2020 Nov;
9.
PMID: 33185189
SARM1, an executor of axonal degeneration, displays NADase activity that depletes the key cellular metabolite, NAD+, in response to nerve injury. The basis of SARM1 inhibition and its activation under...
7.
Sporny M, Guez-Haddad J, Lebendiker M, Ulisse V, Volf A, Mim C, et al.
J Mol Biol
. 2019 Jul;
431(19):3591-3605.
PMID: 31278906
SARM1 induces axonal degeneration in response to various insults and is therefore considered an attractive drug target for the treatment of neuro-degenerative diseases as well as for brain and spinal...
8.
Ren C, Yuan Q, Braun M, Zhang X, Petri B, Zhang J, et al.
Dev Cell
. 2019 Apr;
49(2):206-219.e7.
PMID: 30930167
Cell polarization is important for various biological processes. However, its regulation, particularly initiation, is incompletely understood. Here, we investigated mechanisms by which neutrophils break their symmetry and initiate their cytoskeleton...
9.
Barak R, Yom-Tov G, Guez-Haddad J, Gasri-Plotnitsky L, Maimon R, Cohen-Berkman M, et al.
Cell
. 2019 Mar;
177(2):272-285.e16.
PMID: 30853216
Proper brain function requires high-precision neuronal expansion and wiring, processes controlled by the transmembrane Roundabout (Robo) receptor family and their Slit ligands. Despite their great importance, the molecular mechanism by...
10.
Guez-Haddad J, Yom-Tov G, Opatowsky Y
Structure
. 2018 Feb;
26(2):183-184.
PMID: 29413320
In this issue of Structure,Aleksandrova et al. (2018) present low- and high-resolution structures of Robo1, a key player in axonal guidance. The structures shed light on the arrangement of Robo1...